HomeEBS • NYSE
Emergent Biosolutions Inc
$2.47
After Hours:
$2.40
(2.83%)-0.070
Closed: Mar 18, 6:26:20 PM GMT-4 · USD · NYSE · Disclaimer
StockUS listed securityUS headquartered
Previous close
$2.45
Day range
$2.37 - $2.52
Year range
$1.42 - $13.67
Market cap
128.94M USD
Avg Volume
5.15M
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
Market news
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
276.60M-16.23%
Operating expense
105.90M-4.85%
Net income
-49.50M26.12%
Net profit margin
-17.9011.78%
Earnings per share
-0.77-148.39%
EBITDA
-22.00M-189.43%
Effective tax rate
9.17%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
111.70M-82.84%
Total assets
1.82B-42.42%
Total liabilities
1.17B-34.00%
Total equity
649.30M
Shares outstanding
52.20M
Price to book
0.20
Return on assets
-6.82%
Return on capital
-8.17%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
-49.50M26.12%
Cash from operations
32.10M-65.41%
Cash from investing
-11.40M74.89%
Cash from financing
4.70M-98.67%
Net change in cash
23.90M-94.05%
Free cash flow
35.05M-89.68%
About
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes. Among the company's products are the controversial BioThrax, the only anthrax vaccine licensed by the U.S. Food and Drug Administration and Narcan for the emergency treatment of opioid overdose. The company also manufactures pharmaceuticals for infectious diseases like cholera and typhoid. During the COVID-19 pandemic, Emergent BioSolutions also produced Johnson & Johnson/Janssen and Oxford–AstraZeneca vaccines at one of its plants; however, this was marked by contamination and other production issues, and millions of doses of vaccine had to be discarded. Wikipedia
Founded
Sep 5, 1998
Employees
1,600
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu